iMetabolic Biopharma Corporation

CIK: 1957114NVIncorporated: 2017-11-17

Current Offering

$10,000
Target Amount
$1,230,000
Maximum Amount
2023-03-16
Deadline

Security Details

Type: Convertible Note
Price per share: $0.00
Shares offered: 10,000+

Offering Costs

Cash commission: 9%
Up to 9% percent
Equity compensation: 3%
Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Financial Reports

Offering via StartEngine

Offering History

As of 2022-12-16
Raising $10,000 -$1,230,000 via 10,000+ shares of convertible Note at $0.00 per share
Deadline: 2023-03-16
As of 2023-03-15
Raising $10,000 -$1,230,000 via 10,000+ shares of convertible Note at $0.00 per share
Deadline: 2023-04-30
As of 2023-04-24
Raising $10,000 -$1,230,000 via 10,000+ shares of convertible Note at $0.00 per share
Deadline: 2023-07-06
Filing date2022-12-162023-04-24
Current employees44
Act received most recent fiscal year$0.00$0.00
Act received prior fiscal year$0.00$0.00
Cash equi most recent fiscal year$64,248$4,601
Cash equi prior fiscal year$119,176$64,248
Cost goods sold most recent fiscal year$0.00$0.00
Cost goods sold prior fiscal year$0.00$0.00
Long term debt most recent fiscal year$139,336$161,025
Long term debt prior fiscal year$148,000$155,471
Net income most recent fiscal year-$63,745.00-$94,513.00
Net income prior fiscal year-$22,130.00-$63,745.00
Revenue most recent fiscal year$0.00$0.00
Revenue prior fiscal year$0.00$0.00
Short term debt most recent fiscal year$17,192$0.00
Short term debt prior fiscal year$3,139$0.00
Tax paid most recent fiscal year$0.00$0.00
Tax paid prior fiscal year$0.00$0.00
Total asset most recent fiscal year$64,248$4,601
Total asset prior fiscal year$119,176$64,248

Company Information

Corporation
NV
2017-11-17

Latest Metrics

Employees4
Total Assets$64,248
Cash on Hand$64,248
Revenues$0.00
Net Income-$63,745.00

Crowdfunding Portals

This company is raising funds through this portal